D-Dimer, Quantitative

Test Code
DDIMQ/DDIM1


Alias/See Also
Dimer, Quantitative Dimer


CPT Codes
85379

Preferred Specimen
Citrate BLUE (BLU)


Instructions
Collect whole blood in 3.2% buffered sodium citrate (9:1 blood to sodium citrate). Venipuncture must be atraumatic.  Checking for clots may be done with applicator stick or by visual inspection of centrifuged plasma for small clots


Specimen Stability

  • Centrifuge at 4,500 RPM for 10 minutes. Plasma platelet count should be less than 10,000. Test within eight hours of collection.

  • If testing is to be delayed more than eight hours after collection, immediately separate plasma into a clean, polystyrene tube, cap, and store below -20°C up to 1 month or -70°C up to 6 months.

  • In patients with hematocrit values greater than 55%, the citrate concentration must be adjusted so that a proper plasma/anticoagulant volume is maintained.




Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Reject hemolyzed, clotted, overfilled tubes or short draw (<90%) sample


Setup Schedule
24x7


Reference Range
< 0.50 ug/mL FEU

Interpretation:
D-dimer test results must be interpreted in conjunction
with your clinical assessment of risk for DVT and/or PE.  The
following guidelines are recommended:
 1.  A D-dimer level below 0.50 ug(FEU)/mL in a patient with a low clinical
     risk for DVT/PE essentially excludes that diagnosis. Consider
     alternative diagnoses.
 2.  A D-dimer level below 0.50 ug(FEU)/mL in a patient with a medium or
     high clinical risk for acute DVT/PE does not definitively
     exclude the diagnosis.  Further work-up is suggested.
 3.  A D-dimer level above 0.50 ug(FEU)/mL is of limited diagnostic value,
     as many other conditions are associated with elevated D-dimer
     levels.  If the patient's clinical risk for acute DVT/PE is
     medium or high, further work-up may be indicated.


Clinical Significance
Clinical applications for this test includes:    
  • Disseminated Intravascular Coagulation (DIC), a negative predictor for the diagnosis of a thrombotic episode (i.e., DVT, PE),
  • Efficacy of treatment for a thrombotic episode and screen for possible re-occurrence (MI),
  • Screen for other activation states of coagulation (i.e., post-operative, cancer, cirrhosis).


Performing Laboratory
CRMC Laboratory
CCMC Laboratory
FHSH Laboratory



The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. Any Profile/panel component may be ordered separately. Reflex tests are performed at an additional charge.